Companion Diagnostics Market in North America is expected to register a CAGR of 19.8% during the forecast period (2019-2025) - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report North America Companion Diagnostics Market, published by KBV research, the North America Companion Diagnostics Market would witness market growth of 19.8% CAGR during the forecast period (2019-2025).

The USA market dominated the North America Blood Cancer Companion Diagnostics by Country in 2018, growing at a CAGR of 21 % during the forecast period. The Canada market is expected to witness a CAGR of 21.9% during (2019 - 2025). Additionally, The Mexico market is expected to witness a CAGR of 23.4% during (2019 - 2025).

The Oncology market dominated the Mexico Companion Diagnostics Market by Indication in 2018, growing at a CAGR of 22.8 % during the forecast period. The Neurology market is expected to witness a CAGR of 19.9% during (2019 - 2025).

The Polymerase Chain Reaction (PCR) market dominated the Canada Companion Diagnostics Market by Technology in 2018, growing at a CAGR of 20.5 % during the forecast period. The Immunohistochemistry market is expected to witness a CAGR of 19.3% during (2019 - 2025).

Full Report:https://www.kbvresearch.com/north-america-companion-diagnostics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, Inc., Almac Group, ARUP Laboratories, Inc., Abbott Laboratories (Abbott Laboratories Molecular, Inc.), Danaher Corporation, Thermo Fisher Scientific, Inc., Hologic, Inc., Novartis AG, Illumina, Inc., Qiagen N.V.

North America Companion Diagnostics Market Segmentation

By Technology

  • Immunohistochemistry
  • Polymerase chain reaction (PCR)
  • Next generation sequencing (NGS)
  • In Situ Hybridization and
  • Other Technology

By Indication

  • Oncology
  • Neurology and
  • Other Indications

By Cancer Type

  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Blood Cancer and
  • Other Cancer Type

By Country

  • US Companion Diagnostics Market
  • Canada Companion Diagnostics Market
  • Mexico Companion Diagnostics Market
  • Rest of North America Companion Diagnostics Market

Companies Profiled

  • Agilent Technologies, Inc.
  • Almac Group
  • ARUP Laboratories, Inc.
  • Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Hologic, Inc.
  • Novartis AG
  • Illumina, Inc.
  • Qiagen N.V.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Companion Diagnostics Market Related Reports:

Global Market

Europe Market

Asia Pacific Market

LAMEA Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.